Hypertension Journal Articles

 
 
  • Renal Denervation: Antihypertensive or Gizmo Idolatry? A hypertension expert's view of the current status of renal denervation for resistant hypertension.
  • Accelerometer-Measured Sedentary Behavior and Risk of CVD A study of the association between accelerometer-measured sedentary behavior with risk of specific CV outcomes, including potential relations with moderate to vigorous physical activity
  • Nonpharmacologic Management of Patients With HF A review of the optimal lifestyle recommendations including dietary interventions, exercise, and management of sleep-disordered breathing, mood disorders, and substance use.
  • Oxidized Phospholipids and Calcific Aortic Valvular Disease A study looking at the association of oxidized phospholipids carried by apolipoprotein B-100–containing lipoproteins, including Lp (a), and calcific aortic valve disease.
  • MRAs in HF: Established and Emerging Roles A comprehensive review of the current data on MRAs for HF and the future direction of nonsteroidal MRA research, that also explores the causes of MRA underutilization.
  • Consequences of Discontinuing Long-Term Drugs in HFrEF Currently patients with HF are prescribed many drugs for their lifetime. This paper reviews strategies to assess whether efficacy persists and the potential consequences of discontinuation.
  • Heart Failure Drug Development Over the Eras A summary of current efforts of the Heart Failure Collaboratory that highlights important concepts in the contemporary landscape of HF drug development.
  • Distinct Comorbidity Clusters in Patients With Acute HF Five distinct multimorbidity groups were identified from the RELAX-AHF-2 trial population, showing variations in clinical outcomes.
  • Temporal Trends in Takotsubo Syndrome An analysis of nearly 4,000 cases of Takotsubo syndrome from the InterTAK registry.
  • Obesity and Weight Loss Strategies in Heart Failure A review of published data on the epidemiology of obesity and HF, the rationale and caveats regarding intentional weight loss for patients with HF across lifestyle, surgical, and medication domains.
  • Stable Angina: A Patient-Centered Approach A review of the complementary role of coronary revascularization, optimal medical therapy, and lifestyle interventions in the management of stable angina, and the importance of an approach that targets the pathobiology.
  • Contemporary In-Hospital Decongestion Strategies in HF A large-scale U.S. community-based cohort study of HF hospitalizations reviews contemporary inpatient diuretic practices and clinical predictors of weight loss.
  • Impact of Lp(a) on LDL-C or Apo-B-related Risk of CAD A comparison of the association between LDL-C and LDL-C corrected for Lp(a)-C (LDLLp(a)corr) with incident coronary heart disease.
  • Angina Verification Before PCI An N-of-1 trial to identify which patients achieve greatest symptom relief from percutaneous coronary intervention.
  • HDL Parameters and Risk of Heart Failure The association between HDL particle concentration and size with heart failure is studied in participants from the ARIC, MESA, PREVEND, and Dallas Heart studies.
  • Emergence of Melioidosis in Brazil: A Case Series Melioidosis, caused by the bacteria Burkholderia pseudomallei, is an emerging infectious disease in Brazil, as documented in this series of seven laboratory-confirmed cases.
  • Newly Diagnosed ANCA-associated Vasculitis After COVID-19 SARS-CoV-2 is known to potentially induce or exacerbate autoimmune diseases. This report describes a case of antineutrophil cytoplasmic antibody-associated vasculitis following COVID-19 infection.
  • What Is a Normal Left Ventricular Ejection Fraction? Multiple studies have suggested conflicting LVEF thresholds for predicting outcome in heart failure. Is there is no clear range at which we can say the LVEF is normal?
  • Fleaborne Typhus-Associated Deaths Over 170 cases of fleaborne typhus were reported in Los Angeles county in 2022, including three fatal cases, indicating that the disease is on the rise in that area.
  • Factors for Readmissions After Posterior Lumbar Fusion How accurate are machine learning models at identifying the predictive factors for readmissions after posterior lumbar fusion procedures?